314 related articles for article (PubMed ID: 1909615)
21. In vitro activity of BAY 12-8039, a new fluoroquinolone.
Woodcock JM; Andrews JM; Boswell FJ; Brenwald NP; Wise R
Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Rolston K; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
Sato K; Hoshino K; Tanaka M; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
[TBL] [Abstract][Full Text] [Related]
26. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Bauernfeind A
J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone.
Marshall SA; Jones RN
Antimicrob Agents Chemother; 1993 Dec; 37(12):2747-53. PubMed ID: 8109948
[TBL] [Abstract][Full Text] [Related]
28. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.
Markowitz SM; Williams DS; Hanna CB; Parker JL; Pierce MA; Steele JC
Chemotherapy; 1995; 41(6):477-86. PubMed ID: 8529440
[TBL] [Abstract][Full Text] [Related]
29. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Chin NX; Neu HC
J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone.
Neu HC; Chin NX
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):644-50. PubMed ID: 2506029
[TBL] [Abstract][Full Text] [Related]
31. In vitro activity of E-4868, a new trifluoroquinolone, compared to six similar compounds.
Barrett MS; Jones RN; Erwin ME
Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):134-41. PubMed ID: 8388792
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of T-3761, a new fluoroquinolone.
Muratani T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1992 Oct; 36(10):2293-303. PubMed ID: 1332594
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activity of DV-7751a, a new fluoroquinolone.
Tanaka M; Hoshino K; Ishida H; Sato K; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1993 Oct; 37(10):2112-8. PubMed ID: 8257132
[TBL] [Abstract][Full Text] [Related]
34. Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.
Arpi M; Gahrn-Hansen B; Søgaard P; Bentzon MW
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):141-6. PubMed ID: 3473910
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of PD 127,391, an enhanced-spectrum quinolone.
Wise R; Ashby JP; Andrews JM
Antimicrob Agents Chemother; 1988 Aug; 32(8):1251-6. PubMed ID: 3142350
[TBL] [Abstract][Full Text] [Related]
36. In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency.
Huband MD; Cohen MA; Meservey MA; Roland GE; Yoder SL; Dazer ME; Domagala JM
Antimicrob Agents Chemother; 1993 Dec; 37(12):2563-70. PubMed ID: 8109918
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.
Cohen MA; Huband MD; Mailloux GB; Yoder SL; Roland GE; Heifetz CL
Diagn Microbiol Infect Dis; 1991; 14(5):403-15. PubMed ID: 1665775
[TBL] [Abstract][Full Text] [Related]
38. Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
Borobio MV; Conejo M; Ramirez E; Suarez AI; Perea EJ
Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852
[TBL] [Abstract][Full Text] [Related]
39. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections.
Hoogkamp-Korstanje JA
J Antimicrob Chemother; 1997 Sep; 40(3):427-31. PubMed ID: 9338498
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
